Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3RYA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,032
Award facts
- Contract value 100% obligated
- $11,031.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,031.81 to AmerisourceBergen Drug Corp for the supply of Stelara 45 mg/0.5 mL syringes on December 18, 2025, with an ultimate completion date of December 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, maintains an extensive portfolio of contract awards with the DLA and other government healthcare systems. The company's federal procurement record demonstrates consistent capability to fulfill diverse pharmaceutical supply requirements through open competition, delivering everything from specialty medications and vaccines to medical devices and test kits across multiple therapeutic domains. This delivery order for Stelara, a biologic immunosuppressant medication, represents one of numerous medical commodity transactions supporting military and veteran healthcare systems through AmerisourceBergen's established federal contracting relationships.
Quick answers
Who was awarded contract SPE2DR26F3RYA?
SPE2DR26F3RYA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F3RYA worth?
The government has obligated $11,032 on SPE2DR26F3RYA.
Is contract SPE2DR26F3RYA an order under another contract?
Yes. SPE2DR26F3RYA is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3RYA competed?
The extent of competition for SPE2DR26F3RYA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award